Recent Entries

• Science: Intermittent "recuperation" restores CAR-T cell functi

  by Samantha James May 20, 2021
  Chimeric antigen receptor T cell therapy (referred to as"CAR-T") is increasingly being applied to the treatment of cancer patients. CAR-T cell therapy has shown encouraging results in patients with hematologic cancers, but its anticancer activity may be limited by the functional effectiveness o...

• PROTAC In Focus—Hotspot Targets Under Research

  by Samantha James May 19, 2021
  PROTAC is a novel type of drug that is different from antibodies and traditional small molecule inhibitors, consisting of a linker and two warheads. One end of the PROTAC molecule binds to the target protein, and the other binds to the E3 ubiquitin ligase that can mark the target protein as defectiv...

• 10 Q&As About Monoclonal Antibody (mAb)

  by Samantha James May 18, 2021
  Monoclonal antibodies, mRNA/DNA vaccines, CAR-T cells, etc., are popular biological products nowadays, which play an important role in disease prevention and treatment. Most of these technologies originated in the 1980s, which are independent of each other and developed in concert to jointly protect...

• An Overview of 8 Drugs for Acute Lymphoblastic Leukemia (ALL) T

  by Samantha James May 16, 2021
  Abstract: About 3,000 people younger than age 20 are found to have acute lymphoblastic leukemia (ALL) each year in the United States, and thus the treatment of ALL is always a focus of global scientists. At present, there have already been 8 drugs for the treatment of ALL and this article will brief...

• IntegrateRNA miRNA Services: Powerful Support for miRNA Basic R

  by Samantha James May 15, 2021
  IntegrateRNA, the division of Creative Biogene, is dedicated to offering unique technologies and satisfactory services for RNA discovery, expression analysis, functional research and mechanism analysis, etc. Recently it announced the release of miRNA services ranging from miRNA discovery, confirmati...